Table 1.
Data routinely collected/derived for the HOMER cohort as of 30 June 2012, the study end-date for the HOMER cohort at the time of writing
| Variables | |
|---|---|
| Demographics | Age |
| Sex | |
| Ethnicity | |
| Aboriginal ancestry | |
| Postal code and/or census tract locator | |
| BC Health Authority | |
| Date of death | |
| Cause of death | |
| Clinical/laboratory variables | Year of first HIV-positive test |
| Year of ART initiation | |
| Physician’s experience of monitoring HIV-positive patients | |
| HIV clade | |
| AIDS-defining illnessesa | |
| Absolute CD4 cell count and date | |
| Plasma viral load and date | |
| Hepatitis C infection status | |
| Hepatitis B infection status | |
| Antiretroviral therapy | ART medication (drug, form, dose) |
| Start and stop date for each ART medication | |
| ART drug resistance testing and results | |
| ART adherenceb | |
| Treatment interruptions | |
| Prescribed structured treatment interruptions |
ART: antiretroviral therapy.
aDate is recorded for the first diagnosis of each ADI.
bAdherence is estimated based on pharmacy refill records and is defined as the proportion of time an individual has supply of ART dispensed during follow-up. Threshold for adherence is set at ≥95%.